Investing in Life's Beginning
A GrowShare Capital thesis on high-growth technology for prenatal, delivery, and postnatal care.
Thesis: The Maternal Health Tech Revolution
The journey of motherhood is one of life's most critical periods, yet it remains one of the most underserved by modern technology. GrowShare Capital has identified Maternal Health Technology as a cornerstone of our healthcare investment strategy. This sector represents a multi-billion dollar market opportunity characterized by legacy system inefficiencies, significant care gaps, and a deeply motivated consumer base.
We are not just funding apps; we are investing in platforms that create healthier families, stronger communities, and a new generation of life.
Why This Sector, Why Now?
High-Growth Market
The global FemTech market is projected to reach $1.1 Trillion by 2027, with maternal health as a core driver.
Profound Social Impact
Investments directly contribute to reducing maternal mortality, improving infant health, and closing care gaps.
Data & AI Integration
Our portfolio companies leverage data to create personalized, predictive, and preventative care models.
Core Investment Areas
Remote Monitoring Platforms
Wearables and at-home diagnostic tools for real-time tracking of maternal and fetal health.
Telehealth & Virtual Care
On-demand access to lactation consultants, therapists, and postnatal support networks.
AI-Powered Diagnostics
Algorithms that predict risks like pre-eclampsia and pre-term labor, enabling early intervention.
Our Ideal Partner
We seek early-stage companies (Seed to Series A) with a validated clinical need, a strong founding team combining medical and technical expertise, and a clear path to regulatory approval and reimbursement.
Join Our Thesis
If you are a founder building the future of maternal health or an investor passionate about this space, we invite you to connect with us.
Connect With Our Team